2nd Quarter - Amendment

CAPITOL HILL CONSULTING GROUP for ASTELLAS PHARMA US

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 9, 2008 $30,000 Replaced
2nd Quarter - Amendment (this page) Jul 16, 2008 $30,000 Replaced
2nd Quarter - Amendment Dec 10, 2009 $30,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical and life sciences, including but not limited to, federal organ transplant and anti-infectives policy

LobbyistCovered position, as disclosed
BILL K BREWSTER New —
AMANDA HILL —
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Pharmaceutical and life sciences, including but not limited to: coverage and reimbursement issues under the Medicare and Medicaid programs

LobbyistCovered position, as disclosed
BILL K BREWSTER New —
AMANDA HILL —
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug safety

LobbyistCovered position, as disclosed
BILL K BREWSTER New —
AMANDA HILL —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.